Daily Big Picture : Nifty Gains 1.2%; Glenmark Pharma Receives USFDA Approval

Today’s Action

Nifty, 1.2%; Sensex, +1.3%; Model Portfolio, +1.3%; Nifty Midcap, +1.6%; Smallcap, +1.5%

Daily Market Review

Market Status: Confirmed Uptrend

Benchmark indices recovered sharply from early losses and extended gains to trade at day’s high. The rally was broad-based and all sectors contributed to the cause. In early trading, Nifty fell led by the IT sector, after a media report stating that the U.S. is planning to cap H-1B visas to counter Indian government’s policy of data localization.

Nifty Pharma (+3.1%) was the top gainer today led by Sun Pharm.Industries (+4.1%) and Cipla (+3.3%). Among others, Nifty Auto (+2.5%), Metal (+1.9%), and Bank (+1.4%) followed the suit. The advance-decline ratio was in favor of gainers. Of the 2,093 stocks traded on the NSE, 1,118 advanced, 665 declined, and 310 remained unchanged. This improvement in market breadth is a good sign for further advance.

Today, Nifty just closed below its 21-DMA, which is placed at 11,860.75. Looking forward, Nifty retaking its 21-DMA would be positive for the market. We will also be looking for a follow-through day to enhance our confidence in the market.

Key News

Adani Green Energy: The Company’s arm Adani Renewable Energy Park has bagged a 130-MW wind power project in an auction by state-owned Solar Energy Corporation of India (SECI). The stock was up 3%

Glenmark Pharmaceuticals: The USFDA approved an acne treatment drug Clindamycin Phosphate Foam. The approved product is a generic version of Mylan Pharmaceutical’s Evoclin Foam. According to the Company’s press release for the 12 months to April 2019, Evoclin Foam achieved annual sales of approximately $17M. The stock was up 2%.

Leaders Up on Volume: Aditya Fash.& Retail (+3.5%), Srf (+2.3%), and Kalpataru Power Tnsm. (+1.3%)

Leaders Down on Volume: Wipro (-2.4%) and Tech Mahindra (-1.4%)

What do you think? Please email us any questions or comments.

Continue reading with a MarketSmith India Premium subscription…

To Read Detailed Reports including Stock Recommendations, Idea Lists, Evaluate Stocks etc. Subscribe to MarketSmith India.

Discover more from MarketSmith India Blog

Subscribe now to keep reading and get access to the full archive.

Continue reading